Improved nonclinical safety profile of a novel, highly selective inhibitor of the immunoproteasome subunit LMP7 (M3258)

MLA

Sven Jaeckel, et al. “Improved Nonclinical Safety Profile of a Novel, Highly Selective Inhibitor of the Immunoproteasome Subunit LMP7 (M3258).” Toxicology and Applied Pharmacology, vol. 429, May 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....13c919e2b89172449fad2e560adb0a3a&authtype=sso&custid=ns315887.

APA

Sven Jaeckel, Annika Hansen, Nina Glaser, Sigrid Johannes, Willem Sloot, Valentina Lai, Juergen Hellmann, Anja Knippel, & Manuela Onidi. (2021). Improved nonclinical safety profile of a novel, highly selective inhibitor of the immunoproteasome subunit LMP7 (M3258). Toxicology and Applied Pharmacology, 429.

Chicago

Sven Jaeckel, Annika Hansen, Nina Glaser, Sigrid Johannes, Willem Sloot, Valentina Lai, Juergen Hellmann, Anja Knippel, and Manuela Onidi. 2021. “Improved Nonclinical Safety Profile of a Novel, Highly Selective Inhibitor of the Immunoproteasome Subunit LMP7 (M3258).” Toxicology and Applied Pharmacology 429 (May). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....13c919e2b89172449fad2e560adb0a3a&authtype=sso&custid=ns315887.